Merit Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
4,148
+4
+0.1% +$1.05K 0.01% 1008
2026
Q1
$1.11M Buy
4,144
+219
+6% +$59.3K 0.01% 938
2025
Q4
$985K Sell
3,925
-298
-7% -$79.1K 0.01% 961
2025
Q3
$1.21M Sell
4,223
-171
-4% -$45.8K 0.01% 763
2025
Q2
$1.15M Buy
4,394
+980
+29% +$239K 0.01% 724
2025
Q1
$795K Buy
3,414
+639
+23% +$155K 0.01% 745
2024
Q4
$636K Buy
+2,775
New +$637K 0.01% 639
2024
Q3
Sell
-1,232
Closed -$251K 907
2024
Q2
$251K Buy
+1,232
New +$251K 0.01% 776
2024
Q1
Sell
-1,148
Closed -$261K 902
2023
Q4
$261K Buy
1,148
+105
+10% +$22.1K 0.01% 660
2023
Q3
$210K Sell
1,043
-404
-28% -$85.2K 0.01% 685
2023
Q2
$300K Buy
+1,447
New +$281K 0.01% 594

Other funds holding LH

Merit Financial Group's LH Position: Q2 2026 in Review

Merit Financial Group increased its Labcorp (LH) stake by 0.1% in Q2 2026, buying an estimated $1.05K and bringing the position to 4,148 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1008.

Merit Financial Group first reported a position in LH in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.21M in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Merit Financial Group held 4,148 shares of Labcorp worth $1.16M as of Q2 2026.
  • Merit Financial Group bought 4 Labcorp shares in Q2 2026, an estimated $1.05K.
  • Labcorp made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #1008 holding.
  • Merit Financial Group first reported a position in Labcorp in Q2 2023 and has held it in 11 quarters since.
  • Merit Financial Group's Labcorp position peaked at $1.21M in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.